Event Rate and Effects of Stimulants in ADHD

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

LDX.

"In this study 3 different doses of LDX will be used:~* 30 mg capsules: 30 mg LDX, equivalent to 8.9 mg of dexamphetamine~* 50 mg capsules: 50 mg LDX, equivalent to 14.8 mg of dexamphetamine~* 70 mg capsules: 70 mg LDX, equivalent to 20.8 mg of dexamphetamine"

DRUG

sugar pill

Children will take once only a placebo capsule during the DBPC phase (phase 4) the morning of the testing. For blinding purpose we will blindfold the children when taking placebo.

DEVICE

computer task (Go/No-Go task)

DEVICE

EEG

event-related potentials (ERP) and heart rate measurements

DEVICE

pupil size measurements (by using eye tracking)

Trial Locations (2)

9000

Ghent University Hospital, Ghent

Ghent University, Ghent

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

collaborator

Shire

INDUSTRY

lead

University Ghent

OTHER

NCT01913912 - Event Rate and Effects of Stimulants in ADHD | Biotech Hunter | Biotech Hunter